Radiation myelitis after durvalumab administration following chemoradiotherapy for locally advanced non-small cell lung cancer: an illustrative case report and review of the literature
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2192-3183
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Radiation myelitis after durvalumab administration following chemoradiotherapy for locally advanced non-small cell lung cancer: an illustrative case report and review of the literature ; day:13 ; month:3 ; year:2019 ; pages:1-4
International Cancer Conference journal ; (13.3.2019), 1-4
- Urheber
-
Kubo, Katsumaro
Wadasaki, Koichi
Yamane, Hiroaki
Doi, Mihoko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13691-019-00367-5
- URN
-
urn:nbn:de:101:1-2019040621115052738544
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kubo, Katsumaro
- Wadasaki, Koichi
- Yamane, Hiroaki
- Doi, Mihoko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Preoperative chemoradiotherapy for locally advanced gastric cancer
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
Arzneimittel Profil Durvalumab
Über Myelitis und zwei Faelle von Myelitis acuta : Inaug. Diss.
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Preoperative chemoradiotherapy for locally advanced gastric cancer
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
Arzneimittel Profil Durvalumab
Über Myelitis und zwei Faelle von Myelitis acuta : Inaug. Diss.
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Preoperative chemoradiotherapy for locally advanced gastric cancer
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
Arzneimittel Profil Durvalumab